Dermatitis

Dermatitis is an infection of the skin. The skin may become itchy and progress to a bumpy red rash that may become tender. There may also be pus-filled blisters that are usually found surrounding hair follicles.

What is Dermatitis?

The term dermatitis refers to inflammation of the skin and is usually characterized by a rash, itching and skin lesions such as blisters or pustules that may leak and crust over. A sensation of tingling, burning and stinging are other typical features.

Dimethyl Fumarate Allergy

Treatment and Prevention of Dimethyl Fumarate Allergy

What is Incontinence-Associated Dermatitis?

What Causes Dermatitis?

Dermatitis Symptoms

Cradle Cap - Seborrheic Dermatitis in Newborns

Dermatitis Treatments

Scratching the Surface: Uncovering the Neurological Mystery of Itch

Dermatitis Types

Irritant vs Allergic Contact Dermatitis

Sofa Dermatitis

Latest Dermatitis News and Research

Japanese study links breastfeeding to mixed risks for childhood allergies

Breastfeeding is widely recognized for its important role in supporting a child's early growth and immune system development.

16 Jul 2026

AbbVie Strengthens Immunology Leadership with $10.9 Billion Apogee Therapeutics Acquisition

AbbVie's strategic acquisition of Apogee Therapeutics highlights its commitment to advancing immunology and developing next-generation treatments for patients.

From 10th Dermatology Drug Development Summit 15 Jul 2026

Infrared imaging improves at-home eczema hydration monitoring

Diagnosis and management of atopic dermatitis, a type of eczema, are complicated by skin temperature fluctuations, unclear responses to at-home moisturizers, and measurement systems that don't penetrate into the deep layers of skin affected by disease.

7 Jul 2026

Allergies show a small but significant link to later cancer risk

A systematic review and meta-analysis of 28 cohort-based studies found a weak but statistically significant association between allergic diseases and later cancer incidence. The signal was strongest in the Western Pacific region and among people with asthma, but high heterogeneity and limited subgroup evidence mean the findings require caution.

5 Jul 2026

Doctors clarify differences between two steroid-induced facial skin conditions

Doctors have long confused two steroid-induced facial skin conditions, leading to wrong treatments and poor outcomes.

26 Jun 2026

Gut fungi play key role in pediatric allergic diseases development

Two new studies jointly published in Nature: The Clinical Microbiome reveal that certain species of fungi in the gut play a key role in the development of immune dysregulation and some pediatric allergic diseases - and may be promising targets for new therapies.

23 Jun 2026

Trial identifies 4 grams a day as the tested safe level for L-tyrosine in healthy men

A randomized, crossover trial in healthy adult men found that 4 weeks of L-tyrosine supplementation at doses up to 4 g/day did not cause clinically meaningful changes in safety markers, diet, blood pressure, or body measures. The highest tested dose, 4 g/day, was identified as the no-observed-adverse-effect level under the study’s four-week conditions, although broader and longer-term studies are still needed.

23 Jun 2026

Childhood eczema may limit educational and career opportunities later

Atopic dermatitis (AD), the most common form of eczema, impacts patients' life trajectories beyond the physical scars.

28 May 2026

Silica nanoparticles dampen early allergy signals in mouse mast cells

This in vitro study found that negatively charged SiO2 nanoparticles suppressed antigen-induced degranulation and activation-marker changes in IgE-sensitized mouse bone marrow-derived mast cells. By contrast, mTiO2 nanoparticles showed cytotoxic and pro-inflammatory effects, including enhanced DNP-induced IL-6 release, suggesting nanoparticle composition can shape early allergic immune responses.

24 May 2026

Slow and steady wins: Low-dose peanut immunotherapy safely desensitizes 82% of preschoolers in landmark trial

A Swedish randomized trial found that slow up-dosing peanut oral immunotherapy with a low maintenance dose helped 82% of preschool children achieve sustained peanut tolerance after three years. The approach proved safer than conventional protocols, with severe reactions uncommon and strong family adherence throughout treatment.

10 May 2026

New study highlights rising cleaning product injuries in young children

Researchers from the Center for Injury Research and Policy at Nationwide Children's Hospital have found more than an estimated 240,800 visits to U.S. emergency departments (EDs) associated with household cleaning product-related injuries from 2007 through 2022 for children aged five years and younger.

2 Apr 2026

Math-based model helps optimize treatment for chronic eczema

Anyone with a chronic illness understands the struggle of living with a disease that is deeply unpredictable.

17 Mar 2026

Non-invasive immune monitoring via bandage-like microneedle patches

Researchers at The Jackson Laboratory (JAX), in collaboration with the Massachusetts Institute of Technology (MIT), have developed the first bandage-like microneedle patch that can sample the body's immune responses painlessly from the skin.

2 Mar 2026

Skin of color seminar improves medical students’ diagnosis skills

A seminar improved medical students' ability to identify skin conditions in darker skin tones, addressing diagnostic gaps in diverse patient populations.

23 Feb 2026

Ion channel TRPV4 found to regulate relief after scratching an itch

When you scratch an itch, something tells your brain when to stop. That moment of relief, when scratching feels "enough," is not accidental.

22 Feb 2026

Top early-life factors driving childhood food allergy

This study analyzes 190 research papers to uncover early-life predictors of food allergies in children, highlighting skin barrier health and family history.

12 Feb 2026

Chronic eczema burdens physical and mental health in older people

Eczema is a group of inflammatory and chronic skin conditions, and it is the most common skin disease among older people.

3 Feb 2026

Genetic study reveals immune-related roots of allergic conjunctivitis

Allergic conjunctivitis is one of the most common eye conditions. A new large-scale genetic study shows that susceptibility to the disease is strongly linked to genes that regulate inflammation and immune defense.

26 Jan 2026

Dietary intervention eases celiac symptoms in children but not quality of life

The Gluten3S research group launched a dietary intervention with children who had recently been diagnosed with celiac disease.

14 Jan 2026

Enveda’s third asset to the clinic with US FDA IND clearance: What it means for Inflammatory Bowel Disease

Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry, has announced that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for ENV-6946.

From Hanson Wade Group - 4th Precision Medicine in Inflammatory Bowel Disease Summit 6 Jan 2026